Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 420

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis?

Open access
CHOLONGITAS, E., PAPATHEODORIDIS, G. V., VANGELI, M., TERRENI, N., PATCH, D., BURROUGHS, A. K.·2005·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Prognosis in cirrhotic patients has had a resurgence of interest because of liver transplantation and new therapies for complications of end‐stage cirrhosis. The model for end‐stage liver disease score is now used for allocation in liver transplantation waiting lists, replacing Child‐Turcotte‐Pugh score. However, there is debate as whether it is better in other settings of cirrhosis. Aim: To review studies comparing the accuracy of model for end‐stage liver disease score vs. Child‐Turcotte‐Pugh score in non‐transplant settings. Results: Transjugular intrahepatic portosystemic shunt studies (with 1360 cirrhotics) only one of five, showed model for end‐stage liver disease to be superior to Child‐Turcotte‐Pugh to predict 3‐month mortality, but not for 12‐month mortality. Prognosis of cirrhosis studies (with 2569 patients) none of four showed significant differences between the two scores for either short‐ or long‐term prognosis whereas no differences for variceal bleeding studies (with 411 cirrhotics). Modified Child‐Turcotte‐Pugh score, by adding creatinine, performed similarly to model for end‐stage liver disease score. Hepatic encephalopathy and hyponatraemia (as an index of ascites), both components of Child‐Turcotte‐Pugh score, add to the prognostic performance of model for end‐stage liver disease score. Conclusions: Based on current literature, model for end‐stage liver disease score does not perform better than Child‐Turcotte‐Pugh score in non‐transplant settings. Modified Child‐Turcotte‐Pugh and model for end‐stage liver disease scores need further evaluation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2005.02691.x

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 420

Metadata

Authors
CHOLONGITAS, E., PAPATHEODORIDIS, G. V., VANGELI, M., TERRENI, N., PATCH, D., & BURROUGHS, A. K.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2005-11-02
Volume
22
Issue
11-12
Pages
1079-1089
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2139870153
Cited by
420
References
45
FWCI
0.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? https://app.cochat.ai/papers/10.1111/j.1365-2036.2005.02691.x
The paper
CHOLONGITAS, E., PAPATHEODORIDIS, G. V., VANGELI, M., TERRENI, N., PATCH, D., & BURROUGHS, A. K. (2005). Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2005.02691.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.